DRUG logo

DRUG
Bright Minds Biosciences Inc

7,575
Mkt Cap
$814.88M
Volume
178,607.00
52W High
$123.75
52W Low
$23.18
PE Ratio
-44.45
DRUG Fundamentals
Price
$86.22
Prev Close
$83.26
Open
$83.60
50D MA
$80.73
Beta
1.05
Avg. Volume
178,813.78
EPS (Annual)
-$1.27
P/B
10.31
Loading...
Loading...
News
all
press releases
Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock
Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) major shareholder Cormorant Asset Management, Lp sold 109,331 shares of the company's stock in a transaction dated Tuesday, April 28th...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven analysts that are currently covering the stock...
MarketBeat·14d ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Bright Minds Biosciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·18d ago
News Placeholder
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest
Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 703,646...
MarketBeat·20d ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Bright Minds Biosciences in a research note on Monday. They set a "buy" rating and a $145.00 price objective for the company...
MarketBeat·23d ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap Up - Here's Why
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap Up - Should You Buy...
MarketBeat·29d ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Trading 7.4% Higher - What's Next?
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 7.4% - Here's Why...
MarketBeat·30d ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research
BTIG Research reissued a "buy" rating and issued a $147.00 target price on shares of Bright Minds Biosciences in a research note on Monday...
MarketBeat·1mo ago
News Placeholder
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Moderate Buy" from Brokerages
Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the firm, MarketBeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
Bright Minds Biosciences (NASDAQ:DRUG) Raised to "Hold" at Wall Street Zen
Wall Street Zen upgraded Bright Minds Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest DRUG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.